Precision for Medicine, the first global, precision medicine, clinical research services organization today announced the strategic acquisition of SolveBio, which will now fall under the QuartzBio, part of Precision for Medicine brand and product portfolio.
About Michael Rubin
This author has not written his bio yet.
But we are proud to say that Michael Rubin contributed 1 entries already.
Entries by Michael Rubin
Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.
QUARTZBIO® and the PRECISION QUARTZBIO logo® are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved. The names and logos of other companies and products appearing on the website may be trademarks or registered trademarks of such other companies.